YI ZHENG: Open Payments
NPI 1649713207 · BELLEVUE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 11 payments from 7 companies in 2025. Trend: 2023 $26 · 2024 $100 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 2 | $92 |
| PFIZER INC. | 2 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $48 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $36 |
| ABIOMED | 1 | $28 |
| Amgen Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: Attruby, ELIQUIS, LifeVest, REPATHA, FARXIGA, VERQUVO.
Industry payments across WA — which companies pay providers there.
